| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/11/2014 | US8883807 Piperidinone carboxamide indane CGRP receptor antagonists |
| 11/11/2014 | US8883806 Processes for preparing JAK inhibitors and related intermediate compounds |
| 11/11/2014 | US8883803 Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors |
| 11/11/2014 | US8883802 Co-crystals of a triazolo [4,5-D] pyrimide platelet aggregation inhibitor |
| 11/11/2014 | US8883801 Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors |
| 11/11/2014 | US8883800 Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
| 11/11/2014 | US8883799 Tricyclic PI3K inhibitor compounds and methods of use |
| 11/11/2014 | US8883798 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin E2, method of production thereof and use thereof |
| 11/11/2014 | US8883797 Metalloenzyme inhibitor compounds |
| 11/11/2014 | US8883796 Biphenyl derivatives, pharmaceutical composition comprising the same, and preparation method thereof |
| 11/11/2014 | US8883795 Polymorphic forms of Rifaximin |
| 11/11/2014 | US8883794 Pharmaceutical composition |
| 11/11/2014 | US8883793 Tubulin inhibitors and methods of using the same |
| 11/11/2014 | US8883792 Substituted isoquinoline derivative |
| 11/11/2014 | US8883791 N-heteroaryl compounds with cyclic bridging unit for the treatment of parasitic diseases |
| 11/11/2014 | US8883790 Pharmaceutical combinations |
| 11/11/2014 | US8883789 Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors |
| 11/11/2014 | US8883788 Fused heterocyclic ring compound |
| 11/11/2014 | US8883787 Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting PARP |
| 11/11/2014 | US8883786 Glucocorticoid receptor antagonists |
| 11/11/2014 | US8883785 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 11/11/2014 | US8883784 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 11/11/2014 | US8883783 Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith |
| 11/11/2014 | US8883782 Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use |
| 11/11/2014 | US8883780 Crystal of a benzoxazinone compound |
| 11/11/2014 | US8883779 Oxazine derivatives and a pharmaceutical composition for inhibiting BACE1 containing them |
| 11/11/2014 | US8883778 Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1 |
| 11/11/2014 | US8883777 Compositions controlling pH range of release and/or release rate |
| 11/11/2014 | US8883776 Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine H3 receptor |
| 11/11/2014 | US8883775 Treatment of hyperproliferative diseases with vinca alkaloid N-oxide analogs |
| 11/11/2014 | US8883774 Methods for increasing the stabilization of hypoxia inducible factor-1 alpha |
| 11/11/2014 | US8883773 Cephem compound having pseudo-catechol group |
| 11/11/2014 | US8883772 Broad spectrum beta-lactamase inhibitors |
| 11/11/2014 | US8883771 Bivalent inhibitors of IAP proteins and therapeutic methods using the same |
| 11/11/2014 | US8883770 Synthetic bile acid compositions and methods |
| 11/11/2014 | US8883769 Methods for the treatment of fibromyalgia and chronic fatigue syndrome |
| 11/11/2014 | US8883768 Fluocinolone implants to protect against undesirable bone and cartilage destruction |
| 11/11/2014 | US8883767 Low ether compositions and delivery apparatus |
| 11/11/2014 | US8883766 Ion channel modulators and methods of use |
| 11/11/2014 | US8883765 Anti-cytomegalovirus activity of artemisinin-derived dimers |
| 11/11/2014 | US8883764 Formylpyrrole-based heterocycles for nucleic acid attachment to supports |
| 11/11/2014 | US8883763 Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same |
| 11/11/2014 | US8883762 Solution for peritoneal dialysis |
| 11/11/2014 | US8883761 Use of lipid conjugates in the treatment of diseases associated with vasculature |
| 11/11/2014 | US8883760 Cancer therapy using beta glucan and antibodies |
| 11/11/2014 | US8883759 Anti-tumor effect potentiator |
| 11/11/2014 | US8883758 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof |
| 11/11/2014 | US8883757 Compositions and methods for treatment of ovarian cancer |
| 11/11/2014 | US8883756 SDF-1 delivery for treating ischemic tissue |
| 11/11/2014 | US8883754 Method for inhibiting angiogenesis |
| 11/11/2014 | US8883752 5′ and 2′ BIS-substituted nucleosides and oligomeric compounds prepared therefrom |
| 11/11/2014 | US8883750 Method of treating diabetes |
| 11/11/2014 | US8883749 Transcription factor inhibitors and related compositions, formulations and methods |
| 11/11/2014 | US8883748 Formulation for treating fungal infection |
| 11/11/2014 | US8883747 Topical antifungal compositions and methods of use thereof |
| 11/11/2014 | US8883746 α-galactosylceramide derivatives, pharmaceutically acceptable salts thereof, preparation method and pharmaceutical composition for the immune adjuvant containing the same as an active ingredient |
| 11/11/2014 | US8883745 C—glycolipids with enhanced Th-1 profile |
| 11/11/2014 | US8883744 Method and composition for modulating canonical Wnt pathway using folate and inositol |
| 11/11/2014 | US8883743 Methods for treating obesity employing an SGLT2 inhibitor |
| 11/11/2014 | US8883737 Methods of treating cancer |
| 11/11/2014 | US8883733 Cell cultivation in chitosan alginate hydrogel beads |
| 11/11/2014 | US8883721 Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof |
| 11/11/2014 | US8883715 Biocompatible polymers, process for their preparation and compositions containing them |
| 11/11/2014 | US8883714 Pharmaceutical compositions comprising GPR119 agonists which act as peptide YY (PYY) secretagogues |
| 11/11/2014 | US8883504 Cell differentiation suppressing agent, method of culturing cells using the same, culture solution, and cultured cell line |
| 11/11/2014 | US8883473 Methods of treatment using allosteric processing inhibitors for matrix metalloproteinases |
| 11/11/2014 | US8883426 Use of therapeutically effective lipids and method for producing organ-/tissue-specific therapeutically effective lipids |
| 11/11/2014 | US8883233 Animal feed composition |
| 11/11/2014 | US8883228 Composition for heart disease, its active ingredients, method to prepare same and uses thereof |
| 11/11/2014 | US8883227 Plant pathogen inhibitor combinations and methods of use |
| 11/11/2014 | US8883225 Water-soluble pharmaceutical compositions of hops resins |
| 11/11/2014 | US8883221 Micronutrient combination product for use as a dietetic food supplement in age-related macular degeneration |
| 11/11/2014 | US8883220 Compositions of jasmonate compounds |
| 11/11/2014 | US8883218 Anti-cancer nanoparticle compositions and methods of use |
| 11/11/2014 | US8883217 Modified release formulations containing drug-ion exchange resin complexes |
| 11/11/2014 | US8883209 Pharmaceutical solid dispersions |
| 11/11/2014 | US8883207 Controlled release carvedilol formulation |
| 11/11/2014 | US8883206 Pharmaceutical composition and administrations thereof |
| 11/11/2014 | US8883204 Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same |
| 11/11/2014 | US8883203 Solid oral dosage form containing an enhancer |
| 11/11/2014 | US8883201 Solid oral dosage form containing an enhancer |
| 11/11/2014 | US8883200 Delivery of nucleic acid-like compounds |
| 11/11/2014 | US8883199 Administration regime for N-hydroxy-4-{2-[3-(N,N-dimethylaminomethyl)benzofuran-2- ylcarbonylamino]ethoxy}benzamide |
| 11/11/2014 | US8883198 Transdermal rivastigmine therapeutic system |
| 11/11/2014 | US8883196 Transdermal hormone delivery system: compositions and methods |
| 11/11/2014 | US8883194 Adsorbent-containing hemostatic devices |
| 11/11/2014 | US8883192 Compositions and methods for reducing or preventing obesity |
| 11/11/2014 | US8883190 Urologic devices incorporating collagen inhibitors |
| 11/11/2014 | US8883187 Stabilized compositions containing alkaline labile drugs |
| 11/11/2014 | US8883185 Hydrogel implants with varying degrees of crosslinking |
| 11/11/2014 | US8883182 Method and material for enhanced tissue-biomaterial integration |
| 11/11/2014 | US8883179 Oral care compositions and methods |
| 11/11/2014 | US8883177 Pharmaceutical compositions for parenteral administration |
| 11/11/2014 | US8883148 Prevention of joint destruction |
| 11/11/2014 | US8883139 Compositions and soft tissue replacement methods |
| 11/11/2014 | US8883138 Adiponectin production accelerating composition |
| 11/11/2014 | US8883136 Methods for accelerating the healing of connective tissues injuries and disorders |
| 11/11/2014 | US8883135 Crystalline form of a pyridyl-piperazinyl hepatitis C virus inhibitor |
| 11/11/2014 | US8883133 Pharmaceutical compositions comprising polymeric binders with non-hydrolysable their use in treating celiac disease |
| 11/11/2014 | US8883132 Cosmetic compositions comprising a polar modified polymer and a tackifier |